title: Levosimendan in a case of severe peri-myocarditis associated with influenza A/H1N1 virus.
authors.forename: S
authors.initials: S
authors.lastname: Busani
authors.forename: A
authors.initials: A
authors.lastname: Pasetto
authors.forename: G
authors.initials: G
authors.lastname: Ligabue
authors.forename: V
authors.initials: V
authors.lastname: Malavasi
authors.forename: R
authors.initials: R
authors.lastname: Lugli
authors.forename: M
authors.initials: M
authors.lastname: Girardis
mesh_terms: D002316:Cardiotonic Agents / Q000627:therapeutic use*; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000188:drug therapy* / Q000209:etiology*; D011724:Pyridazines / Q000627:therapeutic use*; D012720:Severity of Illness Index; D000077464:Simendan; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan